Forever Investor https://validator.w3.org/feed/docs/rss2.html Berkshire AGM – A little of the fallout Reverse Engineering Nick Train’s Pepsi Purchase Battle Against Cancer Investment Trust: Doing Good by Doing Well Loews: Hiding In Plain Sight Valuation: Taking the Temperature Tom Russo: Capacity to Suffer If Buffett were British… Free Capital Bob Farrell’s Ten Market Rules to Remember Was that it? Market Neutral Funds: for sophisticated investors only… The Little Book That Beats The Market Why did Loews spin-off Lorillard? In defence of misers Portfolio Update: July Pinstripe Stampede Pinstripe Stampede: a short postscript Pundit Predictions Diageo: Topping-Up Key Ratios: The Enterprise Multiple (Enterprise Value/EBITDA) It’s Only a Game: the Football Talent Fund Portfolio Update: August Scotland: Aye or Nay? JPMorgan Chase: Portfolio Purchase Tesco: Woodford 1 Buffett 0 Bill Gross: King Canute? Portfolio Update: September Berkshire: Flies in the Soup (Part 1) Reckitt Benckiser: Just How Overvalued? GlaxoSmithKline: Is the Dividend Safe? Unilever: Heal Thyself FTSE – It’s a record! (or is it?) Voya Corporate Leaders — The Really Forever Fund Terry Smith and his Six Criteria Alliance Trust: Here we go again… The Most Important Thing Portfolio Update: Q1 The Outsiders AstraZeneca – AGM 2015 Safes, safety, and plunging Patient Capital and Impatient Journalists JP Morgan and the Panic of 1907 Portfolio Update: Q2 Jesse Livermore: Boy Plunger JP Morgan: Then and Now Valeant Pharmaceuticals: The Market Wizards’ Choice PZ Cussons: What’s Not to Like? BACIT: TD Waterhouse Not Supporting the Cash Dividend Asset Allocation – What are the asset classes? Potholes and Dividends